Infections associated with permanent pacemakers and implantable cardioverters-defibrillators;Infekcje systemów stymuluja̧cych serca i kardiowerteró w-defibrylatorów

Kardiologia Polska

Volumn 67, Issue 3, 2009, Pages 305-309

  Mazurek, Maciej ^a   Grzegorzewski, Bogusław ^a   Kargul, Włodzimierz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL HEART PACEMAKER; BACTEREMIA; BLOODSTREAM INFECTION; CLINICAL EXAMINATION; DEFIBRILLATOR; DEVICE INFECTION; HUMAN; INFECTION RISK; MYCOBACTERIUM; REVIEW; SERRATIA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; BACTERIAL ENDOCARDITIS; INFECTION; METHODOLOGY; MICROBIOLOGY; PRIMARY PREVENTION; RISK FACTOR; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION;

BACTEREMIA; DEFIBRILLATORS, IMPLANTABLE; ENDOCARDITIS, BACTERIAL; HUMANS; PACEMAKER, ARTIFICIAL; PRIMARY PREVENTION; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

EID: 66149156289     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Cabell CH, Heindenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries 1990-1999. Am Heart J 2004; 147: 582-586
2. Camus C, Leport C, Raffi F, et al. Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal. Clin Infect Dis 1993; 17: 46-55.
3. Cacoub P, Leprine P, Natal P, et al. Pacemaker infective endocarditis. Am J Cardiol 1998; 82: 480-484
4. Molina JE. Undertreatment and overtreatment of patients with infected antiarrhytmic implantable devices. Ann Thorac Surg 1997; 63: 504-509
5. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001; 104: 1029-1033
6. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacamaker leads: clinical presentation and management. Circulation 1997; 95: 2098-2107
7. Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133: 604-608
8. Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device - related infections. Circulation 2003; 108: 2015-2031
9. Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed intravenously and via thoracotomies: epidemiology, infection control and management. Clin Infect Dis 1998; 27: 265-269
10. Sohail MR, Uslan DZ, Khan AH. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-1859.
11. Dy Chua J, Abdul-Karim A, Mawhorter S, et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin Electrophysiol 2005; 28: 1276-1281
12. Bowler PG, Duerden PI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001; 14:2 44-69.
13. Nynström PO. The microbiological swab sampler - a quantitative experimental investigation. Acta Pathol Microbiol Scand [B] 1978; 86: 361-367
14. Ellenbogen KA, Kay GN, Lau CP, Wilkoff BL (eds.). Clinical cardiac pacing, defibrillation, and resynchronization therapy. Saunders Elsevier, Philadelphia 2007, 912-930
15. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infection. Science 1999; 284: 1318-1322
16. Donlan MR, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-193
17. Laguno M, Miro O, Font C, et al. Pacemaker-related endocarditis. Report of 7 cases and review of the literature. Cardiology 1998; 90: 244-248
18. Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med 1994; 121: 2343-2348
19. Bates DW, Goldman L, Lee Th. Contaminated blood cultures and resourse utilization: the true consequences of false - positive results. JAMA 1991; 265: 365-369
20. Bekeris LG, Tworek JA, Walsh MK, et al. Trends in blood culture contamination: a College of American Patholosts Q-Tracs study of 356 institutions. Arch Pathol Lab Med 2005; 129: 1222-1225
21. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med 2004; 350: 1422-1429
22. Uslan DZ, Sohail S, Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med 2007; 167: 669-675
23. Sohail MR, Uslan DZ, Khan AH. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol 2007; 49: 1851-1859.
24. Bluhm G. Pacemaker infections: a clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med Scand 1985; 699: 1-62.
25. Da Costa A, Levievre H, Kirkorian G, et al. Role of preaxillary flora in pacemaker infections: a prospective study. Circulation 1998; 97: 1791-1795
26. th ed. WBC/McGraw-Hill, Boston 1999, 766-796
27. Chamis AL, Peterson GE, Cabell H, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter- defibrillators. Circulation 2001; 104: 1029-1033
28. Fowler VG Jr, Kong LK, Corey GR, et al. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 1999; 179: 1157-1161
29. Hogevik H, Olaison L, Andersson R, et al. Epidemiologic aspects of infective endocarditis in an urban population: a 5 year prospective study. Medicine (Baltimore) 1995; 74: 324-339
30. Bouza V, Menasalvas E, Munoz A, et al. Infective endocarditis: a prospective study at the end of the twentieth century-new predisposing conditions, new etiologic agents, and still high mortality. Medicine (Baltimore) 2001; 80: 298-307.
31. Hoen B, Alla F, Selton-Sury C, et al. Changing profile of infective endocarditis, results of a 1-year survey in France. JAMA 2002; 288: 75-81.
32. Mathew J, Addai T, Anand A, et al. Clinical features, site of involvement, bacteriologic findings and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995; 155: 1641-1648
33. Arber N, Pras E, Capperman Y, et al. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine 1994; 73: 299-305.
34. Sidhu P, O'Kane H, Ali N, et al. Mechanical or bioprosthetic valves in elderly: a 20-year comparison. Ann Thorac Surg 2001; 71 (5 Suppl.): 257-260
35. Moreillon P, Que YA, Bayer AS. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin North Am 2002; 16: 297-318.
36. Sinha B, Francois P, Que YA, et al. Heterogously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun 2000; 68: 6871-6878
37. Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363: 139-149
38. Strom BL, Abrutyn E, Berlin JA, et al. Dental and cardiac risk factors for infective endocarditis. A population based, case control study. Ann Intern Med 1998; 129: 761-769
39. Li JS, Sexton GJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638
40. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001; 345: 1318-1330
41. Dumont E, Camus C, Victor F, et al. Suspected pacemaker or defibrillator transvenous lead infection. Eur Heart J 2003; 24: 1779-1787
42. Post JJ, Alexopoulos C, Fewtrell C, et al. Outcome after complete percutaneous removal of infected pacemaker systems and implantable cardiac defibrillators. In Med J 2006; 36: 790-792
43. Mela T, Govern BA, Garan H, et al. Long-term infection rate associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol 2001; 88: 750-753
44. Klug D, Balde M, Pavin D, et al. Prospective evaluation of pacemaker leads endocarditis (People study): 12 month incidence and risk factors of pacemakers-related infections. Eur Heart J 2004; 25 (Suppl.): 27.
45. Sohail MR, Khan AH, Freidman PA, et al. Electrophysiologic cardiac deviceinfections: risk factor analysis using a case-control study. Abstract no 43 presented at Infectious Diseases Society of America, San Francisco 2005.
46. Bohm A, Banay F, Preda I, et al. The treatment of septicemia in pacemaker patients. Pacing Clin Electrophysiol 1996; 19: 1105-1111